Anti-IL-23 (Tremfya)(Guselkumab biosimilar) mAb
Produktgrößen
100 µg
£768,00
12-2003-100UG
Über dieses Produkt
- SKU:
- 12-2003
- Klonalität:
- Monoclonal
- Weitere Details:
- Tremfya or Guselkumab biosimilar is human immunoglobulin G1 lambda (IgG1lambda) monoclonal antibody; a member of the interleukin inhibitors that selectively block interleukin-23 p19. It usually is important in the treatment of Psoriasis. IL-23 is an inflammatory cytokine responsible for the induction of psoriatic plaque formation. It activates the CD4+ T-helper (Th17) cell pathway. Guselkumab biosimilar developed by Abeomics is for research use only and should not be used in diagnostic procedures.
- Isotyp:
- IgG1
- Aufreinigung:
- Purified from cell culture supernatant by affinity chromatography
- Reaktivitäten:
- Human
- Versandbedingungen:
- Blue Ice
- Lagerbedingungen:
- Store at -20[o]C to -80[o]C (Avoid repeated freezing and thawing).
- Hersteller:
- Abeomics
- Typ:
- Antibodies:Monoclonal Antibody
- Datenblatt des Herstellers:12-2003 Tremfya Coomassie 031423.jpg